Valion Bio (VBIO) Change in Inventory (2021 - 2025)
Valion Bio (VBIO) posted Change in Inventory of -$16.2 million for Q4 2025, down 18921.18% on a QoQ basis from -$85000.0 in Q3 2025, and down 179744.44% year-over-year from N/an in Q4 2024.
Powered by 
Analysis
Valion Bio (VBIO) Change in Inventory (2021 - 2025) Analysis & Trends
Valion Bio has reported Change in Inventory for 5 years, with the latest figure at -$16.2 million in Q4 2025.
- On a quarterly basis, Change in Inventory fell 179744.44% year-over-year to -$16.2 million in Q4 2025; TTM through Dec 2025 was -$16.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$16.3 million, changed N/A from the prior year.
- Change in Inventory was -$16.2 million for Q4 2025 at Valion Bio, down from -$85000.0 in the prior quarter.
- The five-year high for Change in Inventory was $386000.0 in Q2 2022, with the low at -$16.2 million in Q4 2025.
- Average Change in Inventory over 5 years is -$827000.0, with a median of $12000.0 recorded in 2024.
- The sharpest annual moves came in 2022 and 2025: Change in Inventory surged 687.76% in 2022, then plunged 179744.44% in 2025.
- Over 5 years, Change in Inventory stood at $139000.0 in 2021, then fell by 26.62% to $102000.0 in 2022, then slumped by 237.25% to -$140000.0 in 2023, then soared by 106.43% to $9000.0 in 2024, then slumped by 179744.44% to -$16.2 million in 2025.
- The last three Change in Inventory figures came in at -$16.2 million (Q4 2025), -$85000.0 (Q3 2025), and $13000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 31.00 Mn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 145.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 27.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 28.20 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 132.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -280,000.00 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -75.70 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Valion Bio | 298,792.01 | -1.90 Mn | -45,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -16.17 Mn |
| Sep 30, 2025 | -85,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | -13,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | -35,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Dec 31, 2023 | -140,000.00 |
| Sep 30, 2023 | -60,000.00 |
| Jun 30, 2023 | 45,000.00 |
| Mar 31, 2023 | 80,000.00 |
| Dec 31, 2022 | 102,000.00 |
| Sep 30, 2022 | -72,000.00 |
| Jun 30, 2022 | 386,000.00 |
| Mar 31, 2022 | 18,000.00 |
| Dec 31, 2021 | 139,000.00 |
| Jun 30, 2021 | 49,000.00 |
| Mar 31, 2021 | -7,000.00 |